LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)

LPCN

Item 8.01 Other Events

On January 27, 2022, the Company issued a press release announcing the publication of peer reviewed Phase 3 study results for TLANDO. The press release is filed as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

The following exhibits are filed with this report:

© Edgar Online, source Glimpses